D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy.
CXCR4
D-peptide-based probe
PET imaging
cancer
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
05 Oct 2021
05 Oct 2021
Historique:
received:
13
08
2021
revised:
16
09
2021
accepted:
29
09
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
Positron emission tomography (PET) imaging of the C-X-C chemokine receptor 4 (CXCR4) with [
Identifiants
pubmed: 34683912
pii: pharmaceutics13101619
doi: 10.3390/pharmaceutics13101619
pmc: PMC8537445
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Stichting Tegen Kanker
ID : C/2020/1528
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 12R3119N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : I001719N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G0H1216N
Références
Biochem Biophys Res Commun. 2013 Jun 14;435(4):646-50
pubmed: 23688427
Theranostics. 2017 Jun 11;7(9):2350-2362
pubmed: 28744319
Biochemistry. 2000 Apr 4;39(13):3782-7
pubmed: 10736178
Stem Cells Dev. 2012 Aug 10;21(12):2142-51
pubmed: 22121892
Theranostics. 2015 Mar 01;5(6):618-30
pubmed: 25825601
J Nucl Med. 2005 Oct;46(10):1696-700
pubmed: 16204720
J Pharm Biomed Anal. 2015;111:209-14
pubmed: 25898315
Tomography. 2016 Jun;2(2):85-93
pubmed: 30042959
J Med Chem. 2017 Jun 22;60(12):4735-4779
pubmed: 28165741
J Vis Exp. 2018 Mar 10;(133):
pubmed: 29578516
Adv Cancer Res. 2014;124:31-82
pubmed: 25287686
Sci Rep. 2019 Oct 25;9(1):15284
pubmed: 31653903
J Mol Med (Berl). 2014 May;92(5):433-9
pubmed: 24722947
Nature. 2001 Mar 1;410(6824):50-6
pubmed: 11242036
EJNMMI Radiopharm Chem. 2020 Nov 12;5(1):25
pubmed: 33180205
Nat Protoc. 2012 May 17;7(6):1138-44
pubmed: 22596226
EJNMMI Res. 2013 May 08;3(1):36
pubmed: 23651690
J Nucl Med. 2017 Sep;58(Suppl 2):77S-82S
pubmed: 28864616
J Nucl Med. 2017 Sep;58(9):1435-1441
pubmed: 28450554
J Nucl Med. 2016 Feb;57(2):248-51
pubmed: 26564323
J Nucl Med. 2020 Jan;61(1):123-128
pubmed: 31201250
J Biol Chem. 2002 May 17;277(20):17476-85
pubmed: 11880384
EJNMMI Radiopharm Chem. 2020 Jan 29;5(1):4
pubmed: 31997090
Ann Nucl Med. 2018 Oct;32(8):503-511
pubmed: 30105558
Biochemistry. 2014 Aug 5;53(30):4881-3
pubmed: 25058910
Theranostics. 2017 Jul 14;7(11):2924-2939
pubmed: 28824726
Theranostics. 2020 Jul 9;10(18):8264-8280
pubmed: 32724470
Br J Pharmacol. 2020 Aug;177(16):3617-3624
pubmed: 32662519